ArticleInternational journal of clinical oncology2021

The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score.

Yoshihiko Yonekawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.